Brief: Gb Sciences' Plant-Based Formulations Designed To Treat Anxiety Achieve Statistical Significance In Animal Study
24/10/2022 13:47
Oct 24 (Reuters) - GB Sciences Inc GBLX.PK :
* GB SCIENCES' PLANT-BASED FORMULATIONS DESIGNED TO TREAT
ANXIETY
ACHIEVE STATISTICAL SIGNIFICANCE IN ANIMAL STUDY
Source text for Eikon: ID:nGNX4WbTQ4
Further company coverage: GBLX.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GB Sciences
See all newsBrief: Gb Sciences' Plant-Based Formulations Designed To Treat Anxiety Achieve Statistical Significance In Animal Study
Brief: Gb Sciences Inc - Reported Positive Results From A Study Of Its Potential Treatment For Cytokine Release Syndrome
Brief: GB Sciences Sells Its Louisiana Medical Marijuana Business
Brief: GB Sciences Files Novel Patent Application
Brief: GB Sciences Announces The Appointment Of John Davis As Executive VP And General Counsel